A Midwestern Doctor
November’s Open Thread
Within her testimony, one particular recording she made was particularly illuminating as a doctor perfectly illustrated the dysfunctional mentality that has infected our medical system by stating he was unwilling to try any alternative therapy (which had some evidence behind it) for patients he knew would otherwise die.
Much of this in turn, was due to a series of standardized treatment protocols being created for COVID-19, which heavily financially incentivized remdesivir and then ventilator care while simultaneously avoiding an effective off-patent treatment for COVID-19. Despite remdesivir actually increasing the death rate from COVID-19, hospital administrators still pushed their doctors to use it (and retaliated against those who did not follow the NIH COVID protocols) because of how powerful the financial incentives were for doing so.
Note: the NIH COVID treatment panel continued to make remdesivir the standard of care for COVID-19 and forbid alternative therapies (e.g., ivermectin) even as a mountain of evidence piled up that argued against it. This was due to Anthony Fauci appointing the committee and selecting chairs that had direct financial ties to Remdesivir’s manufacturer—an issue that sadly holds true for many other committees which create the guidelines that dictate medical care in the United States (e.g., in a previous article I showed how America’s cholesterol guidelines were authored by individuals taking money from statin manufacturers and that the conclusions those panels reached were the exact opposite of an independent one which evaluated the same data)…
Over the years a variety of remarkable technologies have been developed which significantly improve hospital outcomes, but due to political reasons (e.g., a desire to eliminate competition) they vanished from our hospitals. Since hospital outcomes are the area where the largest and most rapid benefit can often be detected with those forgotten therapies, I have long felt that hospital trials of them would be one of the most effective ways to positively improve the practice of medicine. In turn, once RFK announced his candidacy, a key goal here became to gradually present the therapies which I feel would be the most beneficial in the hospital setting.
For example, here, I presented a strong case ultraviolet blood irradiation would profoundly improve a wide range of hospital outcomes, here I made the case that DMSO would do the same (for a narrower set of conditions), and here I presented some of the evidence that routine IV vitamin C could dramatically reduce the death rate from sepsis (which is the number one killer in our hospitals).
However, those are just a few of the potential approaches that can be utilized. In the final part of this article (which exists an open forum for you enquire about any topics you’ve wanted to ask about such as unanswered DMSO questions) I will discuss some of the approaches (and doses for them) we believe would most benefit hospitalized patients and a few of the tricks we’ve found for identifying the best hospital and doctor to work with (assuming a word of mouth referral is not available to you).